Russian drugmakers eye expansion in Latin American region

22 August 2023

Leading Russian drugmakers are expanding in the Latin American region by beginning to supply their drugs to regional markets and strengthening of their local presence.

One such companies is Pharmasyntez – one of Russia’s leading drugmakers, which has recently began supplying its anti-cancer drugs, as well as drugs for the treatment of diabetes mellitus and HIV to Ecuador.

An executive director of the company, Nikita Punia, said in an interview with the Russian Vedomosti business paper, the company has already received the necessary permission for such supplies. Other details are not disclosed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber



Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight

More Features in Pharmaceutical